ArticleAlzheimer's & dementia (New York, N. Y.)
Implementing robust amyloid PET quantification in multi-center studies: AMYPAD approach to address data acquisition, processing, interpretation and data sharing challenges.
Article in Alzheimer's & dementia (New York, N. Y.). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Implementing robust amyloid PET quantification in multi-center studies: AMYPAD approach to address data acquisition, processing, interpretation and data sharing challenges.Alzheimer's & dementia (New York, N. Y.)Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionAmyloid-positron emission tomography (PET) is pivotal to Alzheimer's management, with the Centiloid standardizing measurements across tracers. AMYPAD trials (Diagnostic and Patient Management Study [DPMS] and Prognostic and Natural History Study [PNHS]) aimed to validate robust quantification in clinical settings. We report our comprehensive approach to amyloid-PET implementation, comprising scan acquisition, harmonization, data storing, and data sharing strategies.
methodsData from 28 scanners were harmonized using Hoffman phantoms. Three quantification workflows were compared: AmyPype (PET-only), IXICO-LEAP, and the standard Centiloid pipeline (magnetic resonance imaging [MRI]-based). Distributions of Centiloids were assessed using Gaussian Mixture Modeling.
resultsBinary quantification showed excellent concordance between pipelines (≥ 96%) and compared to visual reads (>90%). DPMS Centiloids had a bimodal distribution while the PNHS showed a more skewed distribution toward higher Centiloids modeled with three Gaussians (1 DISCUSSION: The harmonization framework, providing strong cross-method correlations in AMYPAD, has been adopted by EARL as the Brain PET/CT accreditation standard and provides a practical approach for other multi-center cohorts to implement similar strategies. Highlights: We share AMYPAD's end-to-end approach to amyloid positron emission tomography (PET) quantification from data acquisition and handling, harmonization based on Hoffman phantoms, quality control, image processing, to data storage, and data sharing strategies.Centiloid quantification was compared across one PET-only (AmyPype) and two PET-MR pipelines (standard Centiloid and IXIXO-LEAP). Excellent agreement in dichotomized Centiloid valued was observed both between pipelines and when compared to visual reads.Distribution of Centiloid values in the Prognostic and Natural History Study (PNHS) and Diagnostic and Patient Management Study (DPMS) are in line with the initial recruitment strategies of the trials.Harmonization of Amyloid-PET scans framework was adopted by EARL as the Brain PET/CT accreditation standard for multicentre brain PET scans.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.